Viewing Study NCT00036569

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:52 PM
Ignite Modification Date: 2026-01-01 @ 7:39 AM
Study NCT ID: NCT00036569
Status: COMPLETED
Last Update Posted: 2012-02-13
First Post: 2002-05-10
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Phase II Study of Pegylated Interferon Alfa 2b (PEG-Intron(Trademark)) in Children With Diffuse Pontine Gliomas
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diffuse Intrinsic Pontine Glioma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Brainstem Glioma View
None Pediatric View
None Interferon View
None MR Imaging View
None Angiogenesis View
None Brain Tumor View
None Glioma View
None Pediatric Brain Tumor View